Developer docs
API playgroundTry for free, no card

Search company profiles

Dante Genomics

Full company profile

uuid000b188

Namestring
Dante Genomics
Legal namestring
Dante Omics
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Dante Genomics, doing business as Dante Omics (also historically Dante Labs), operates a multi-omics solutions platform delivering clinical-grade genomic sequencing and AI-powered interpretation. The product portfolio spans Whole Genome Sequencing, Whole Exome Sequencing, transcriptomics, proteomics, epigenetics, metagenomics, single-cell sequencing, spatial sequencing, long-read sequencing (Oxford Nanopore and PacBio), GWAS, and specialized clinical applications including oncology, liquid biopsy, solid tumor profiling, minimal residual disease detection, pharmacogenomics, newborn screening, NIPT, and carrier screening. The platform is supported by the proprietary AVANTI NGS data analysis software and an AI GPU-accelerated multi-omics engine that the company claims delivers results in days rather than months. Additional solution offerings include "Clinical Lab in a Box" — a packaged deployment for organizations seeking in-house genomic testing capabilities — and a library of 150+ omics reports.

The company operates a B2B enterprise sales motion with quote-based, multi-year contract pricing, targeting five primary use-case segments: Diagnostics companies and clinical labs, academic and commercial Researchers (including biopharma drug discovery), Concierge Doctors offering personalized medicine, Rare Disease testing providers, and Oncology applications. Geographic reach spans 97 countries. Strategic partnerships include AWS (Generative AI for Health) and NVIDIA (GTC 2025), positioning Dante within the leading cloud and AI-compute ecosystems. The website discloses scale metrics of 1 million genomic analyses completed and 100,000+ genomic samples analyzed, but does not disclose revenue, headcount, funding history, or management team details.

Short descriptiontext

Dante Omics is a multi-omics platform offering clinical-grade genomic sequencing and AI-powered interpretation across WGS, WES, transcriptomics, proteomics, and epigenetics, serving diagnostics companies, researchers, biopharma, and clinical labs in 97 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
genomic sequencing services, whole genome sequencing, multi-omics analysis, bioinformatics software, clinical genomic testing
Industry7 codes
PRIMARYHLAAANAF
Multi-Omics Precision Medicine Platforms (genomics/proteomics/metabolomics)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGANAA
Genomics & Next-Generation Sequencing (NGS) Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGANAC
Single-Cell & Spatial Omics Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGANAF
Epigenomics & Chromatin Profiling Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAAAMAJ
Genomic & Multi-Omic Biomarkers (NGS panels, transcriptomics, proteomics, metabolomics)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code3 codes
  • Medical Laboratories621511
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Software Publishers5132
SIC code2 codes
  • Services-Medical Laboratories8071
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Genomic Sequencing & Multi-omics Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Genomic Sequencing Services
TypeOne Time License
Description

Clinical-grade genomic sequencing services including Whole Genome Sequencing, Whole Exome Sequencing, and specialized panels for diagnostics, research, and pharmaceutical applications

danteomics.com
2Multi-Omics Analysis Services
TypeProfessional Services
Description

Advanced multiomics analysis including transcriptomics, proteomics, epigenetics, and bioinformatics services for biopharma and research

danteomics.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Operations, Personnel, Marketing or Sales, Infrastructure
Pricing details1 tier
1Enterprise/Quote-based pricing
ModelOtherBilling cadenceMulti-year contract
Notes

No public pricing available - 'Get a Quote' CTAs throughout site indicate B2B enterprise sales model with custom pricing based on project scope

danteomics.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1AVANTI
Description

NGS Data Analysis Software for genomic data processing and interpretation

danteomics.com
Core offering1 text field

Dante Omics provides clinical-grade genomic sequencing and multi-omics analysis services, including Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), transcriptomics, proteomics, epigenetics, metagenomics, and single-cell and spatial sequencing. The platform combines these sequencing capabilities with an AI-powered, GPU-accelerated bioinformatics pipeline and the AVANTI NGS data analysis software to deliver interpreted genomic reports to diagnostics labs, researchers, biopharma, and healthcare institutions globally.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Deliver results in days rather than months
Product overview1 text field

Dante Omics is a multi-omics solutions platform offering a comprehensive portfolio of genomic services and AI-powered analysis. The platform operates as a unified offering combining clinical-grade sequencing (Whole Genome Sequencing, Whole Exome Sequencing), specialized applications (Oncology, Pharmacogenomics, NIPT, Newborn Screening, Carrier Screening), and advanced multi-omics services (Transcriptomics, Proteomics, Epigenetics, Metagenomics, Single-cell, Spatial Sequencing, Long Reads, GWAS). The portfolio includes the AVANTI bioinformatics software platform for NGS data analysis, and supporting solutions like Clinical Lab in a Box for in-house laboratory setup and Genomic Reports for delivering results. All services are powered by AI for interpretation and analysis, with capabilities spanning diagnostics, biopharma research, and population genomics applications.

Product and service1 record
1Whole Genome Sequencing (WGS)
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Participation in NVIDIA GTC 2025 AI Conference for Developers, demonstrating GPU acceleration capabilities for multiomics platform. NVIDIA's AI computing platform enables advanced genomic data analysis.

2AWS | Generative AI for Health
Strategic tierCoreTypeTechnology or Integration
Description

Collaboration with AWS for generative AI in health applications, showcasing integration with major cloud infrastructure provider for genomic data processing and analysis.

danteomics.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Personalis is a clinical genomics and molecular diagnostics company offering WGS/WES and an AI-driven interpretation platform focused on oncology, including MRD and tumor profiling. It directly overlaps with Dante's oncology, liquid biopsy, and MRD services.

TypeEmerging player
Description

Element Biosciences develops novel sequencing platforms and works with service providers on multi-omics applications. While primarily an instrument vendor, its AVITI system competes in the sequencing ecosystem that Dante's AVANTI software and clinical sequencing services are built upon.

TypeDirect peer
Description

Nebula Genomics offers WGS, WES, and multi-omics interpretation with an emphasis on privacy-enabled, AI-driven analysis. It directly competes with Dante on consumer and research-oriented whole genome sequencing products and bioinformatics interpretation.

TypeDirect peer
Description

BGI Genomics operates one of the world's largest genomic sequencing service businesses spanning WGS, WES, NIPT, oncology, and rare disease. It is the closest direct peer to Dante Omics in terms of clinical-grade sequencing service breadth, multi-omics scope, and global delivery footprint.

TypeDirect peer
Description

Helix operates a clinical-grade sequencing platform serving health systems, biopharma, and population genomics programs, with a software and 'lab-in-a-box' style offering. Its end-to-end model and population health focus overlap significantly with Dante's clinical sequencing and Clinical Lab in a Box solution.

TypeBroad incumbent
Description

Illumina is the dominant NGS instrument and sequencing services provider. While primarily a platform/tools vendor, its clinical sequencing services and GRAIL-adjacent oncology efforts overlap with Dante's clinical-grade WGS/WES and oncology offerings, making it the broadest incumbent peer.

TypeBroad incumbent
Description

Myriad Genetics is an established clinical genetic testing company with a deep menu in hereditary cancer, pharmacogenomics, and rare disease. It overlaps with Dante's clinical applications including pharmacogenomics, carrier screening, newborn screening, and rare disease diagnostics.

8Tempus AI
TypeBroad incumbent
Description

Tempus AI combines multi-modal data, AI, and sequencing for oncology and precision medicine, including WES/WTS, liquid biopsy, and RNAseq. While broader in scope, its multi-omics + AI interpretation thesis directly parallels Dante's positioning for biopharma and clinical oncology customers.

TypeDirect peer
Description

Eurofins Genomics is a global genomic services provider offering WGS, WES, Sanger sequencing, oligonucleotides, and bioinformatics. It is a comparable direct peer in multi-omics service delivery, custom panels, and biopharma research support across many of the same geographies as Dante.

TypeDirect peer
Description

Color Health provides clinical-grade genetic testing across hereditary cancer, pharmacogenomics, and population health, with an enterprise sales motion to employers, providers, and biopharma. It competes with Dante's clinical sequencing, pharmacogenomics, and population genomics use cases.

Market position
Strengths1 record

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Dante Genomics

Genomic Sequencing & Multi-omics Servicesdantegenomics.com

Dante Omics is a multi-omics platform offering clinical-grade genomic sequencing and AI-powered interpretation across WGS, WES, transcriptomics, proteomics, and epigenetics, serving diagnostics companies, researchers, biopharma, and clinical labs in 97 countries.

What Dante Genomics does

Dante Genomics, doing business as Dante Omics (also historically Dante Labs), operates a multi-omics solutions platform delivering clinical-grade genomic sequencing and AI-powered interpretation. The product portfolio spans Whole Genome Sequencing, Whole Exome Sequencing, transcriptomics, proteomics, epigenetics, metagenomics, single-cell sequencing, spatial sequencing, long-read sequencing (Oxford Nanopore and PacBio), GWAS, and specialized clinical applications including oncology, liquid biopsy, solid tumor profiling, minimal residual disease detection, pharmacogenomics, newborn screening, NIPT, and carrier screening. The platform is supported by the proprietary AVANTI NGS data analysis software and an AI GPU-accelerated multi-omics engine that the company claims delivers results in days rather than months. Additional solution offerings include "Clinical Lab in a Box" — a packaged deployment for organizations seeking in-house genomic testing capabilities — and a library of 150+ omics reports.

The company operates a B2B enterprise sales motion with quote-based, multi-year contract pricing, targeting five primary use-case segments: Diagnostics companies and clinical labs, academic and commercial Researchers (including biopharma drug discovery), Concierge Doctors offering personalized medicine, Rare Disease testing providers, and Oncology applications. Geographic reach spans 97 countries. Strategic partnerships include AWS (Generative AI for Health) and NVIDIA (GTC 2025), positioning Dante within the leading cloud and AI-compute ecosystems. The website discloses scale metrics of 1 million genomic analyses completed and 100,000+ genomic samples analyzed, but does not disclose revenue, headcount, funding history, or management team details.

Dante Genomics firmographics

Firmographics
Name
Dante Genomics
Legal name
Dante Omics
Website
https://dantegenomics.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
51–100 employees
Short description
Dante Omics is a multi-omics platform offering clinical-grade genomic sequencing and AI-powered interpretation across WGS, WES, transcriptomics, proteomics, and epigenetics, serving diagnostics companies, researchers, biopharma, and clinical labs in 97 countries.
Ownership category
akta.pro rank

Dante Genomics industry classification

Industry
Product category
Genomic Sequencing & Multi-omics Services
NAICS
Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Software Publishers (5132)
SIC
Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAAANAF
Multi-Omics Precision Medicine Platforms (genomics/proteomics/metabolomics)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGANAA
Genomics & Next-Generation Sequencing (NGS) Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGANAC
Single-Cell & Spatial Omics Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGANAF
Epigenomics & Chromatin Profiling Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAAAMAJ
Genomic & Multi-Omic Biomarkers (NGS panels, transcriptomics, proteomics, metabolomics)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Genomic sequencing services
  • Whole genome sequencing
  • Multi-omics analysis
  • Bioinformatics software
  • Clinical genomic testing

Where Dante Genomics is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Markets served

Dante Genomics business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Technology or R&D, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

  1. Genomic Sequencing Services: Clinical-grade genomic sequencing services including Whole Genome Sequencing, Whole Exome Sequencing, and specialized panels for diagnostics, research, and pharmaceutical applications
  2. Multi-Omics Analysis Services: Advanced multiomics analysis including transcriptomics, proteomics, epigenetics, and bioinformatics services for biopharma and research

Pricing tiers

ModelBillingPrice
OtherMulti-year contractEnterprise/Quote-based pricing

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Dante Genomics product offering

Product offering

Core offering

Dante Omics provides clinical-grade genomic sequencing and multi-omics analysis services, including Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), transcriptomics, proteomics, epigenetics, metagenomics, and single-cell and spatial sequencing. The platform combines these sequencing capabilities with an AI-powered, GPU-accelerated bioinformatics pipeline and the AVANTI NGS data analysis software to deliver interpreted genomic reports to diagnostics labs, researchers, biopharma, and healthcare institutions globally.

Product overview

Dante Omics is a multi-omics solutions platform offering a comprehensive portfolio of genomic services and AI-powered analysis. The platform operates as a unified offering combining clinical-grade sequencing (Whole Genome Sequencing, Whole Exome Sequencing), specialized applications (Oncology, Pharmacogenomics, NIPT, Newborn Screening, Carrier Screening), and advanced multi-omics services (Transcriptomics, Proteomics, Epigenetics, Metagenomics, Single-cell, Spatial Sequencing, Long Reads, GWAS). The portfolio includes the AVANTI bioinformatics software platform for NGS data analysis, and supporting solutions like Clinical Lab in a Box for in-house laboratory setup and Genomic Reports for delivering results. All services are powered by AI for interpretation and analysis, with capabilities spanning diagnostics, biopharma research, and population genomics applications.

Differentiator

Problem solved

Functional benefit

Brands

  • AVANTI: NGS Data Analysis Software for genomic data processing and interpretation

Products and services

  • Whole Genome Sequencing (WGS)

Quantifiable outcome

  • Deliver results in days rather than months

Companies that use Dante Genomics

Customer profile

Segments5 records

Ideal customer profiles4 records

Dante Genomics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature3 records

Dante Genomics partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • NVIDIA GTC 2025coreStrategic or Co-development Partner · 1 January 2025Participation in NVIDIA GTC 2025 AI Conference for Developers, demonstrating GPU acceleration capabilities for multiomics platform. NVIDIA's AI computing platform enables advanced genomic data analysis.
  • AWS | Generative AI for HealthcoreTechnology or IntegrationCollaboration with AWS for generative AI in health applications, showcasing integration with major cloud infrastructure provider for genomic data processing and analysis.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Dante Genomics competitors and assessment

Company assessment

Direct peers

  • Personalis: Personalis is a clinical genomics and molecular diagnostics company offering WGS/WES and an AI-driven interpretation platform focused on oncology, including MRD and tumor profiling. It directly overlaps with Dante's oncology, liquid biopsy, and MRD services.
  • Nebula Genomics: Nebula Genomics offers WGS, WES, and multi-omics interpretation with an emphasis on privacy-enabled, AI-driven analysis. It directly competes with Dante on consumer and research-oriented whole genome sequencing products and bioinformatics interpretation.
  • BGI Genomics: BGI Genomics operates one of the world's largest genomic sequencing service businesses spanning WGS, WES, NIPT, oncology, and rare disease. It is the closest direct peer to Dante Omics in terms of clinical-grade sequencing service breadth, multi-omics scope, and global delivery footprint.
  • Helix: Helix operates a clinical-grade sequencing platform serving health systems, biopharma, and population genomics programs, with a software and 'lab-in-a-box' style offering. Its end-to-end model and population health focus overlap significantly with Dante's clinical sequencing and Clinical Lab in a Box solution.
  • Eurofins Genomics: Eurofins Genomics is a global genomic services provider offering WGS, WES, Sanger sequencing, oligonucleotides, and bioinformatics. It is a comparable direct peer in multi-omics service delivery, custom panels, and biopharma research support across many of the same geographies as Dante.
  • Color Health: Color Health provides clinical-grade genetic testing across hereditary cancer, pharmacogenomics, and population health, with an enterprise sales motion to employers, providers, and biopharma. It competes with Dante's clinical sequencing, pharmacogenomics, and population genomics use cases.

Emerging players

  • Element Biosciences: Element Biosciences develops novel sequencing platforms and works with service providers on multi-omics applications. While primarily an instrument vendor, its AVITI system competes in the sequencing ecosystem that Dante's AVANTI software and clinical sequencing services are built upon.

Broad incumbents

  • Illumina: Illumina is the dominant NGS instrument and sequencing services provider. While primarily a platform/tools vendor, its clinical sequencing services and GRAIL-adjacent oncology efforts overlap with Dante's clinical-grade WGS/WES and oncology offerings, making it the broadest incumbent peer.
  • Myriad Genetics: Myriad Genetics is an established clinical genetic testing company with a deep menu in hereditary cancer, pharmacogenomics, and rare disease. It overlaps with Dante's clinical applications including pharmacogenomics, carrier screening, newborn screening, and rare disease diagnostics.
  • Tempus AI: Tempus AI combines multi-modal data, AI, and sequencing for oncology and precision medicine, including WES/WTS, liquid biopsy, and RNAseq. While broader in scope, its multi-omics + AI interpretation thesis directly parallels Dante's positioning for biopharma and clinical oncology customers.

Market position

Strengths1 record

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Dante Genomics social profiles

Digital presence

Dante Genomics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Dante Genomics leadership team

Management profile

Number of profiles

Dante Genomics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Dante Genomics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dante Genomics

What does Dante Genomics do?

Dante Omics provides clinical-grade genomic sequencing and multi-omics analysis services, including Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), transcriptomics, proteomics, epigenetics, metagenomics, and single-cell and spatial sequencing. The platform combines these sequencing capabilities with an AI-powered, GPU-accelerated bioinformatics pipeline and the AVANTI NGS data analysis software to deliver interpreted genomic reports to diagnostics labs, researchers, biopharma, and healthcare institutions globally.

Is Dante Genomics a public or private company?

Dante Genomics is a private company. It is classified as unknown and is currently operating.

When was Dante Genomics founded?

Dante Genomics was founded in 2016. It employs 51 to 100 people.

Where is Dante Genomics based?

Dante Genomics is headquartered in New York, United States, in the North America region.

How does Dante Genomics make money?

Two revenue lines are on record. Genomic Sequencing Services are the primary driver. The others are multi-Omics Analysis Services.

Who are Dante Genomics's main competitors?

Direct peers on record are Personalis, Nebula Genomics, BGI Genomics, Helix, Eurofins Genomics and Color Health. Element Biosciences is listed as an emerging player. Broad incumbents are Illumina, Myriad Genetics and Tempus AI.

Does Dante Genomics have an API?

No public API is recorded for Dante Genomics.

What industry is Dante Genomics in?

Dante Genomics's product category is Genomic Sequencing & Multi-omics Services. Its primary akta.pro industry code is HLAAANAF, Multi-Omics Precision Medicine Platforms (genomics/proteomics/metabolomics), with a secondary code of HLAGANAI, Bioinformatics, Multi-Omics Data Analysis & Interpretation Services. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogDante Genomics to Launch Generative AI Features in Dante Labs Whole Genome PlatformDante Genomics will integrate Generative AI features into its Dante Labs Whole Genome platform, announced today. The AI tools aim to reduce processing times and provide personalized narrative reports, with global availability starting Q1 2025 and early access to select customers.PR NewswireGenomic Data Revolutionizes GCC Healthcare MarketResearchAndMarkets.com published a market report forecasting significant growth in the GCC Genomics Services Market from 2024 to 2028, driven by rising chronic disease prevalence, declining sequencing costs (from over $1 billion in 2003 to under $1,000 today), and government healthcare investments. The report highlights Saudi Arabia's allocation of 5.69% of GDP to healthcare in 2019 and cites specific cancer statistics including approximately 27,885 new cancer cases in Saudi Arabia and 4,807 in the UAE in 2020. Key market players identified include Igenomix Dubai, G42 Healthcare-Saphetor, Dante Genomics, and Eurofins Scientific among others operating in the region.PR NewswireDante Genomics s'associe à Amazon Web Services (AWS) pour lancer une plateforme d'IA révolutionnaire au service de la médecine de précision et la médecine génomiqueDante Genomics, a global leader in genomics and precision medicine, announced a strategic AI collaboration with Amazon Web Services to deploy generative AI for clinical care of patients with genetic diseases. The partnership leverages Amazon Bedrock on AWS to build large language models for genomic medicine, utilizing Dante's database of over 130 genomic reports and one of the largest private genome databases with research consent. The collaboration will enable exploration of phenotypes such as eye color, ancestry, and monogenic diseases through a chat-like interface, potentially revolutionizing the daily application of genomic data in personalized medicine.DesignrushAWS and Dante Genomics Launch New AI PlatformAWS and Dante Genomics launched an AI platform using Amazon Bedrock to create a large language model for personalized medicine in genomic diseases. The platform will let customers navigate over 130 reports via a chat interface. AWS is also investing $100 million in a generative AI center.PR NewswireDante Genomics schließt sich mit Amazon Web Services (AWS) zusammen, um eine bahnbrechende KI-Plattform für Präzisionsmedizin und klinische Genomik einzuführenDante Genomics, a global genomics and precision medicine company, announced a strategic AI partnership with Amazon Web Services (AWS) to integrate generative AI into clinical patient care for genetically caused diseases. The collaboration leverages Amazon Bedrock, an LLM platform on AWS, to help Dante's customers navigate its growing collection of over 130 genomic reports across clinical areas including proactive screening, longevity, and personalized medicine. The system aims to enable phenotype exploration through a chat-like interface to identify monogenetic disorders and comorbidities, representing a pioneering use case for LLMs in genomic medicine.PR NewswireDante Genomics se asocia con Amazon Web Services (AWS)Dante Genomics announced a strategic AI collaboration with Amazon Web Services (AWS) to launch an innovative platform using Amazon Bedrock to create a large language model for clinical genomics and precision medicine. The platform will enable Dante's customers to access and navigate over 130 genomic reports through a chat-style interface to explore phenotypes like eye color, ancestry, and monogenic disorders such as cardiomyopathies and respiratory conditions. This partnership positions Dante Genomics to advance the application of genomic data in personalized medicine by leveraging AWS's technology infrastructure.PR NewswireDante Genomics partners with Amazon Web Services (AWS) to launch groundbreaking AI platform for precision medicine and clinical genomicsDante Genomics, a global leader in genomics and precision medicine, announced a strategic AI collaboration with Amazon Web Services (AWS) to bring generative AI to clinical care of patients with genomic diseases. Dante will utilize Amazon Bedrock to build large language models (LLMs) for clinical genomics, leveraging its database of more than 130 genomic reports and expertise in whole genome sequencing. The collaboration aims to enable a chat-style interface for exploring phenotypes and genetic conditions, representing what both parties describe as a groundbreaking use case for LLMs in personalized medicine.PR NewswireDante Genomics partners with Amazon Web Services (AWS) to launch groundbreaking AI platform for precision medicine and clinical genomicsDante Genomics announced a strategic AI collaboration with Amazon Web Services to build a large language model for clinical genomics using Amazon Bedrock. The platform will enable chat-style exploration of phenotypes like eye color, ancestry, and monogenic disorders, leveraging Dante's whole genome sequencing data.PR NewswireL'organisation de défense des patients POIC e dintorni APS et Dante Genomics concluent une alliance pour apporter des solutions de séquençage du génome entier aux patients atteints de maladies rares,POIC e dintorni APS, a patient advocacy organization, and Dante Genomics, a global genomic medicine company, have entered into a strategic partnership to accelerate whole genome sequencing solutions for patients with Megacystis Microcolon Microcolon Intestinal Hypoperistalsis Syndrome (MMIHS) and Chronic Intestinal Pseudo-Obstruction (POIC) mediated by ACTG2. The collaboration, presented at the 2nd World Congress of Pediatric Neurogastroenterology and Motility in Columbus, Ohio, aims to leverage Dante Genomics' advanced genomic analysis capabilities alongside POIC's clinical expertise to provide partially subsidized genome sequencing access and drive research into these rare disorders.PR NewswirePOIC e dintorni APS und Dante Genomics bilden eine Allianz, um Patienten Lösungen für die Ganzgenomsequenzierung anzubieten. Die Partnerschaft wird auf dem 2. Weltkongress für pädiatrische NeurogastroPOIC e dintorni APS and Dante Genomics have formed a strategic partnership to provide whole genome sequencing solutions for patients with ACTG2-mediated Megacystis Microcolon Intestinal Hypoperistalsis Syndrome and Chronic Intestinal Pseudo-Obstruction, two rare and complex gastrointestinal disorders. The collaboration aims to leverage Dante Genomics' advanced genomic analysis technologies and POIC's expertise in pediatric gastrointestinal motility to identify genomic solutions and expand patient access to partially subsidized whole genome sequencing. The partnership was officially presented at the 2nd World Congress for Pediatric Neurogastroenterology and Motility held September 7-9, 2023 in Columbus, Ohio, USA.